CPT Codes for Molecular Pathology

effective January 1, 2012

Effective 1/1/2012, the AMA is implementing 100+ new CPT codes for molecular pathology. These new codes will eventually replace the current "stacking" codes (83890-83914). Even though the AMA is making the new codes effective, the national Medicare office is not pricing the codes for 2012. In fact, they are leaving it up to each local Medicare carrier to determine if they want to accept and pay the new codes in 2012.

Because of the uncertainty with payers, Mayo Medical Laboratories will continue to invoice our clients in the same manner as we do today using the stacking codes. However, starting on 1/1/2012, both the "new" CPT code and the stacking codes will be indicated in the test catalog. Pricing and test structure will not be impacted.

View Molecular Pathology Tests that include new CPT codes

The following illustrates how new CPT codes will be displayed in the test catalog as of 1/1/2012:

Mayo Test ID
BCRAB
Secondary ID
89007
Reporting Name
BCR/ABL, p210, Quant, Monitor
Published Name
BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML)
Method Name
Quantitative Reverse Transcription-Polymerase Chain
Reaction (RT-PCR) using GeneXpert (Cepheid)
(PCR is utilized pursuant to a license agreement
with Roche Molecular Systems, Inc.)

CPT Code Information
81206 / BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative

For nonparticipating payers
BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML)
83891-Isolation or extraction of highly purified nucleic acid
83896 x 2-Nucleic acid probe, each
83898 x 2-Amplification, target, each nucleic acid sequence
83902-Reverse transcription
Interpretation and Report
83912